NCT01848457: Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy |
|
|
| Completed | 2 | 13 | US | Pantoprazole, Protonix IV, High-dose methotrexate infusion duration, Otrexup (PF), Xatmep, Trexall | Children's Hospital of Philadelphia, Gateway for Cancer Research | Osteosarcoma, Nephrotoxicity, Ototoxicity | 01/16 | 10/16 | | |
